Kemnay Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Buy
243
+10
+4% +$838 ﹤0.01% 687
2026
Q1
$18.7K Sell
233
-87
-27% -$7.17K ﹤0.01% 731
2025
Q4
$27.3K Buy
+320
New +$26.3K ﹤0.01% 458

Other funds holding EW

Kemnay Advisory Services's EW Position: Q2 2026 in Review

Kemnay Advisory Services increased its Edwards Lifesciences (EW) stake by 4.3% in Q2 2026, buying an estimated $838 and bringing the position to 243 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Kemnay Advisory Services first reported a position in EW in Q4 2025 and has held it in 3 quarters since. The position peaked at $27.3K in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kemnay Advisory Services held 243 shares of Edwards Lifesciences worth $22K as of Q2 2026.
  • Kemnay Advisory Services bought 10 Edwards Lifesciences shares in Q2 2026, an estimated $838.
  • Edwards Lifesciences made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #687 holding.
  • Kemnay Advisory Services first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • Kemnay Advisory Services's Edwards Lifesciences position peaked at $27.3K in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.